Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 573.95
-7.65 (-1.32%)
At close: Jan 19, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 138.61 billion as of January 23, 2026. Its market cap has decreased by -5.90% in one year.
Market Cap
138.61B
Enterprise Value
150.49B
Revenue
48.42B
Ranking
n/a
PE Ratio
27.01
Stock Price
573.95
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 138.61B, an increase of 84,574.59%. That is a compound annual growth rate of 34.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 137.10B | -5.61% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 385.24B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.20B |
| Caplin Point Laboratories | 132.36B |
| Rubicon Research | 109.37B |
| Sanofi India | 93.06B |
| Procter & Gamble Health | 90.41B |